Nuvectis Pharma, Inc.
A clinical-stage biopharmaceutical company developing targeted therapeutics for cancer.
NVCT | US
Overview
Corporate Details
- ISIN(s):
- US67080T1088
- LEI:
- Country:
- United States of America
- Address:
- 1 BRIDGE PLAZA, SUITE 275, 7024 FORT LEE
- Website:
- https://nuvectis.com/
- Sector:
- Manufacturing
Description
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines and novel targeted therapeutics for the treatment of cancer. The company aims to address serious conditions with unmet medical needs within oncology. Its development pipeline includes the product candidate NXP800.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all Nuvectis Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nuvectis Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nuvectis Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
